Clinical Trials Directory

Trials / Completed

CompletedNCT05971823

Effects of Electronic Cigarette Flavors on Abuse Liability in Smokers (P3-Taste)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if abuse liability indices will be impacted by varying flavors and e-cigarette (ECIG) nicotine delivery capability (i.e., nicotine flux) among current combustible cigarette users. The investigators will compare abuse liability indices between three FDA-authorized ECIG products that vary in nicotine flux (but are all tobacco flavor) and own brand cigarettes. The investigators will also test the influence of ECIG flavor availability (tobacco vs. menthol) within three ECIG product classes.

Conditions

Interventions

TypeNameDescription
OTHERTobacco product administration and assessmentSubjective measures 1 is followed by product sampling that includes 5 self-directed ECIG/own brand cigarette puffs over 10 minutes. After sampling is complete participants complete subjective measures 2. Ten minutes after their sampling has been completed, they complete subjective measures 3 and the behavioral economic task(s). These activities are preceded and followed by cardiovascular response assessment.

Timeline

Start date
2023-07-31
Primary completion
2024-07-26
Completion
2024-07-26
First posted
2023-08-02
Last updated
2026-04-06
Results posted
2026-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05971823. Inclusion in this directory is not an endorsement.